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Abstract
It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and
African populations use traditional medicine (TM) to meet their healthcare needs; however, this
statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM
use and the characteristics of those who access it, to inform health policy-makers as countries seek
to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of re-
ported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM
users were compared with users of modern healthcare in univariate and multivariate analyses.
Characteristics examined included age, sex, geography (urban/rural), income quintile, education,
self-reported health and presence of specific chronic conditions. This study found TM use was
highest in India, 11.7% of people reported that their most frequent source of care during the previ-
ous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast<3% reported
TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa;
and<2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In uni-
variate analyses, poorer, less educated and rural participants were more likely to be TM-users. In
the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were
associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less preva-
lent in TM users. In Ghana and India, lower income, depression and hypertension were associated
with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unneces-
sary, and perhaps futile, to seek to employ TM for population health needs when populations are
increasingly using modern medicine.
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Key Messages
• Traditional medicine (TM) use is infrequent in China, Ghana, Mexico, Russia and South Africa and much less frequent
than commonly reported in India.
• It may be unnecessary, and perhaps futile, to seek to harness TM for population health needs (as stipulated by the WHO
Traditional Medicine Strategy 2014–23) when populations are demonstrating a preference for modern medicine.
VC The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Introduction
It is frequently stated in the scientific literature (Stekelenburg et al.
2005; Tilburt and Kaptchuk 2008; Birhan et al. 2011; Mbatha et al.
2012; Sato 2012b; Gude 2013; Merriam 2013; Ekor 2014), official
fact sheets and reports (WHO 2002, 2008; Kasilo et al. 2010) and
the press (BBC News 2014; Modern Ghana 2014) that 80% of peo-
ple in Asian and African countries (or sometimes that 80% of the
world’s population) use traditional medicine (TM) practitioners to
meet their primary healthcare needs. This statistic has also been
used in policy-making and in defence of traditional, complementary
and alternative medicine (King and Homsy 1997; UN 2009; ABC
News 2014; Disabled-World 2014). However, when a piece of in-
formation becomes widely quoted it may become accepted without
question and continue to be used, even though it has long been out
of date. Kate Wilkinson traced the use of this statistic and found
that it is likely to have originated in a World Health Organisation
(WHO) textbook published in 1983, with the original data on which
it was based now lost (Traditional Medicine and Health Care
Coverage 1983; Africa Fact Check Blog 2014). More recent data
suggest that the use of TM in some Asian and African countries is
substantially lower and is on the decline (Peltzer 2009; Nxumalo
2011; Angmo 2012; Sato 2012a; Awiti 2014; Mee et al. 2014).
In low- and middle-income countries where the number of prac-
titioners of modern medicine may not be enough to meet the health
care needs of the country, TM and its practitioners are considered
an important resource for population health. Compared to modern
medicine, TM is perceived to be more affordable, accessible and ac-
ceptable to the communities in which it operates (Sato 2012b).
Integration of TM and modern medicine has been recommended by
the WHO since 1978 (WHO 2002). The recently published WHO
Traditional Medicine Strategy 2014–23 has two key goals, one of
which is to support Member States in harnessing the potential con-
tribution of traditional and complementary medicine to health, well-
ness and people-centred health care (WHO 2013).
The extent to which the WHO goal can be realized will depend
on the demand for TM services. Up-to-date knowledge of the preva-
lence of TM use and the characteristics of those who access this kind
of health care is therefore necessary. We have examined these ques-
tions in survey data from six populous middle-income countries.
Methods
Participants and data
Study participants were adults aged 18 years and over who were
part of the WHO Study on Global AGEing and Adult Health
(SAGE) (available at http://www.who.int/healthinfo/sage/cohorts/
en/index2.html). Participants were surveyed between 2007 and
2010 (Wave 1) in six middle-income countries: China, Ghana,
India, Mexico, Russia and South Africa. SAGE used a clustered
household sampling strategy designed to generate nationally repre-
sentative cohorts of older people (over 50 years of age) with data
collected on younger people for comparison. One household ques-
tionnaire was completed for each selected household in face-to-face
interviews, and individual questionnaires were collected from one
randomly selected individual aged 18–49 years and all individuals
aged over 50 years (including by proxy where an individual was un-
able to complete the questionnaire). Individual response rates var-
ied—53% in Mexico, 68% in India, 75% in South Africa, 81% in
Ghana, 83% in Russia and 93% in China. Further details of SAGE
have been published elsewhere (Kowal et al. 2012) Although the
main interest of this article lies in examining use of TM in Asian and
African countries, analysis of Mexican and Russian data was done
for completeness, and for comparison. Participants were excluded
from the study if they did not respond to questions on their health
care use over the previous three years.
The SAGE study received human subjects testing and ethics
council approval from the research review boards local to each par-
ticipating site and from the WHO Ethical Review Committee.
Written informed consent was obtained from each respondent be-
fore interview and examination. A standard consent form, approved
by the WHO ethics review committee, was read to the respondent in
the respondent’s language.
Outcome variables
WHO-SAGE participants were asked two questions, which were
used to examine use of TM. First, they were asked ‘Thinking about
health care you needed in the last 3 years, where did you go “most
often” when you felt sick or needed to consult someone about your
health?’. Second, participants were asked questions relating to con-
tact with health care providers over the last 12 months. If the par-
ticipant reported that they had made contact with a health care
provider in the last year, then they were asked ‘which was the health
care provider you visited?’ and provided with a list of possible re-
sponses including the local terms for traditional healers. Each par-
ticipant was asked about a maximum of three encounters with
health professionals that occurred within the last 12 months. The re-
sults from these questions are recorded in Table 1.
To further examine the characteristics of TM users, we chose to
use the latter question only, this is because it is likely to be less vul-
nerable to recall bias, as it examines the last 12 months, rather than
the last 3 years. We therefore classified anyone who reported at least
one consultation with a TM practitioner in the last 12 months as a
TM user. For comparison we defined those who had at least one
contact with a health care provider in the last 12 months, but who
did not report contact with a TM practitioner as modern health care
users.
Other variables
Participant characteristics examined included sex and geography
(urban or rural) analysed as binary variables; income quintile, edu-
cation (grouped as: primary or less; secondary; tertiary or more) and
self-reported health (very good; good; moderate; bad; very bad) ana-
lysed as ordinal categorical variables; and age (grouped as:<40; 40–
49; 50–59; 60–69; 70þ) analysed in the univariate analysis both as
an ordinal categorical variable and as a nominal variable (see
Statistical analysis section below), and in the multivariate analysis as
a categorical variable with age 70þ as the reference category.
Presence of one of a list of chronic diseases identified by the sur-
vey was also examined as a participant characteristic. These were:
arthritis, stroke, angina, diabetes, chronic obstructive pulmonary
disease, asthma, depression, hypertension and cataracts. For each
chronic disease examined, except diabetes, there were questions
relating to participant-reported doctor diagnosis, alongside data
items allowing recording of probable undiagnosed disease. Two ex-
amples are given in Box 1 below.
In order to identify undiagnosed hypertension, three blood pres-
sure readings were taken from all participants. Hypertension was
defined as an average systolic blood pressure over 140 or average
diastolic blood pressure over 90. There were no questions or
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objective measurements taken in order to identify undiagnosed dia-
betes, therefore only diagnosed diabetes has been examined here.
Finally, we examined costs of consultation with a health care
provider. Participants who reported contact with a health care pro-
vider in the last 12 months were asked how much they, or their
household, paid in relation to this contact. Costs were analysed as
continuous variables in the local currency in which they were
recorded.
Statistical analysis
Descriptive statistics are used to characterize the study population.
Survey weights were used for these to give results representative of
the general national populations from which the study populations
were drawn.
To examine the association between our variables of interest and
use of TM we did univariate and multivariate analyses. Univariate
analyses were carried out using the Pearson correlation co-efficient
if the independent variable was ordinal categorical; Fisher’s exact
test if the independent variable was binary; and Pearson’s v2 test
alongside Pearson’s correlation co-efficient for age-group to address
whether age was associated with use of TM in a non-linear fashion.
Multivariate logistic regression was used to examine the inde-
pendent association of the variables of interest with use of TM. All
those variables that were significantly associated with TM use in
univariate analyses were included in the models. Due to significant
correlation between education, income quintile and geography, edu-
cation was dropped from the model to reduce collinearity. Survey
weights were not used in these analyses. Data were analysed in
STATA/SE version 13.
Results
The study included 35 334 participants after 4857 (12.1%) were
excluded due to missing data on their health care use over the previ-
ous three years. Of these, 23 851 (67.5%) participants reported at
least one contact with health services in the previous 12 months. A
total of 50 154 consultations were discussed in interviews. Table 1
presents the characteristics of the participants in each country.
When asked where they went most frequently over the previous
3 years when they felt sick or needed to consult someone about their
health, <1% of participants in China, Mexico and Russia reported
going to a TM practitioner. Just 40 (1.7%) participants in South
Africa and 123 (1.5%) participants in Ghana reported that they had
used TM (percentages adjusted for survey design, therefore nation-
ally representative). In contrast, 984 (11.7%) of participants in
India reported that they most frequently visited traditional healers
when they felt sick or needed to consult someone about their health
(Table 1).
The number of participants who reported at least one TM con-
sultation over the previous 12 months was higher than the number
reporting that TM was their most frequent source of care over the
past 3 years in China (666 participants, 9.4%) and in India (1852
participants, 19.0%), but lower in South Africa (3 participants,
0.02%). The percentage of all consultations reported by participants
that were with a practitioner of TM varied from <1% in Mexico,
Russia and South Africa, 3.1% in Ghana, 8.5% in China, to 20.0%
in India (Table 1).
Univariate analyses, examining characteristics of people who re-
ported using TM over the previous 12 months compared with those
who reported other medical contact in the previous 12 months, were
only conducted in datasets from China, Ghana and India, as the
number of people who reported using TM over the previous 12
months in Mexico, Russia and South Africa were too low to make
any meaningful conclusions. These results are presented in Table 2.
In the China, Ghana and India univariate analyses, income quin-
tile, education and geography were associated with use of TM, with
poorer, less educated and rural participants more likely to report use
of TM in the last 12 months (Table 2).
In China, age group and self-reported health, as well as the pres-
ence of arthritis, diabetes, hypertension and cataracts were also
associated with use of TM. Users of TM were younger, had worse
self-reported health, and were also more likely to have arthritis;
however, they were less likely to have hypertension, cataracts or
doctor-diagnosed diabetes (Table 2).
In Ghana, univariate analyses showed that older participants
were more likely to use TM. As in China, they had worse self-re-
ported health. Hypertension showed the opposite association to the
China data, i.e. those using TM were more likely to have high blood
pressure. Users of TM were also more likely to have depression
(Table 2).
In India, univariate analysis showed that although age group and
self-reported health were not associated with use of TM, there were
associations with several of the diseases examined. Depression and
cataracts were more common in those treated with TM, whereas an-
gina, hypertension and doctor-diagnosed diabetes were more preva-
lent in those using modern medicine. In addition, the total cost to
the household was lower for users of TM in India (R183.80) than
for users of modern medicine (R518.8) (there was no association
seen with total cost of consultation and use of TM in China or
Ghana) (Table 2).
Multivariate analysis examined those who had reported use of
TM in the previous 12 months compared with those who had any
Box 1.
Asthma
1. Have you ever been diagnosed with asthma (an allergic re-
spiratory disease)?
2. During the last 12 months have you experienced any of the
following:
a. Attacks of wheezing or whistling breathing?
b. Attack of wheezing that came on after you stopped
exercising or some other physical activity?
c. A feeling of tightness in your chest?
d. Have you woken up with a feeling of tightness in your
chest in the morning or any other time?
e. Have you had an attack of shortness of breath that
came on without obvious cause when you were not
exercising or doing some physical activity?
Stroke
1. Have you ever been told by a health professional that you
have had a ‘stroke’?
2. Have you ever suffered from ‘sudden onset’ of paralysis or
weakness in your arms or legs on ‘one side’ of your body
for >24 h?
3. Have you ever had for >24 h ‘sudden onset’ of loss of feel-
ing on ‘one side’ of your body without anything having
happened to you immediately before?
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other medical contact in the previous 12 months. There was a high
degree of correlation between geography, income quintile and edu-
cation in the three countries studied. For this reason, education was
excluded from the multivariate analyses to reduce multi-collinearity
(Table 3).
In the multivariate analysis of data from China, rurality was
associated with use of TM. Worsening self-reported health and
prevalence of arthritis were also associated with use of TM. TM
users were less likely to have doctor-diagnosed diabetes and hyper-
tension and cataracts were less prevalent in TM users. Age was asso-
ciated with use of TM, with 40–49 year olds more likely to use TM
and 50–59 year olds less likely to use TM compared with the over
70s. The association between income quintile and use of TM was re-
versed in this multivariate analysis, with increasing income associ-
ated with increasing use of TM (Table 3).
In Ghana and India, results were very similar. Rurality was not
associated with use of TM. Increasing income was associated with
reduced use of TM. Depression and hypertension were both more
prevalent in users of TM. Age was not associated with use of TM in
the Ghana analysis (and not included as a variable in the India ana-
lysis). Presence of angina, diabetes and cataracts and total cost of
consultation were not associated with TM use in the India analysis
(and not included as variables in the Ghana analysis) (Table 3).
Discussion
This study has found that use of TM in six populous middle-income
countries is much lower than has previously been reported. The
country with the greatest reported use of TM is India, where 11.7%
Table 1. Characteristics of study participants [n (%) adjusted %] (unless otherwise indicated)
China Ghana India Mexico Russia South Africa
No. of participants 11 284 4661 9970 2346 3662 3411
Age group
<40 485 (4.3) 29.8 380 (8.2) 39.7 2859 (28.7) 49.7 196 (8.4) 51.8 189 (5.2) 37.2 187 (5.5) 44.7
40–49 669 (5.9) 44.3 325 (7.0) 34.7 1264 (12.7) 25.1 167 (7.1) 21.7 138 (3.8) 21.5 125 (3.7) 31.2
50–59 4222 (37.4) 11.7 1531 (32.9) 10.4 2584 (25.9) 12.3 382 (16.3) 12.7 1188 (32.4) 18.7 1335 (39.2) 12.0
60–69 3100 (27.5) 8.2 1107 (23.8) 7.0 2007 (20.1) 7.7 819 (34.9) 6.8 927 (25.3) 10.2 992 (29.1) 7.4
70þ 2808 (24.9) 6.0 1318 (28.3) 8.3 1256 (12.6) 5.2 775 (33.0) 7.0 1220 (33.3) 12.5 770 (22.6) 4.7
Female 6207 (55.0) 49.1 2260 (48.5) 50.4 6193 (62.1) 50.3 1477 (63.0) 52.0 2438 (66.6) 55.0 1988 (58.3) 52.8
Income quintile
1 (poorest) 2087 (18.6) 9.9 883 (19.0) 15.1 1750 (17.6) 20.3 480 (20.5) 16.6 608 (16.6) 12.7 593 (17.5) 18.9
2 2135 (19.0) 15.9 907 (19.5) 18.2 1911 (19.3) 21.2 484 (20.7) 23.3 710 (19.4) 12.8 637 (18.8) 19.5
3 2234 (19.9) 18.3 920 (19.8) 19.0 1912 (19.3) 19.9 418 (17.8) 20.1 749 (20.5) 16.5 658 (19.4) 20.5
4 2402 (21.4) 23.4 979 (21.0) 22.4 2093 (21.1) 18.0 491 (21.0) 15.4 751 (20.5) 23.5 739 (21.8) 19.4
5 (richest) 2370 (21.1) 32.6 965 (20.7) 25.3 2252 (22.7) 20.6 470 (20.1) 24.6 840 (23.0) 34.5 763 (22.5) 21.8
Education
Primary or less 6690 (59.3) 37.7 3424 (73.9) 63.4 7142 (71.6) 61.4 1804 (76.9) 51.7 370 (10.1) 3.2 2030 (70.6) 37.5
Secondary 2405 (21.3) 32.1 255 (5.5) 10.8 1196 (12) 15.7 245 (10.4) 23.5 663 (18.1) 10.9 429 (14.9) 27.1
Tertiary or more 2189 (19.4) 30.3 953 (20.6) 25.7 1632 (16.4) 23.0 297 (12.7) 24.8 2627 (71.8) 8.6 417 (14.5) 35.4
Urban 5526 (49.0) 48.7 1928 (41.4) 46.0 2583 (25.9) 25.7 1701 (72.5) 77.8 2776 (75.8) 81.5 2346 (68.9) 69.3
Self-reported health
Very good 397 (3.5) 10.7 303 (6.5) 16.3 437 (4.4) 8.1 79 (3.4) 7.0 23 (0.6) 1.9 181 (5.3) 17.9
Good 3227 (28.6) 42.8 1748 (37.5) 47.3 3326 (33.4) 43.3 859 (36.6) 50.3 478 (13.1) 37.3 1107 (32.5) 44.5
Moderate 5165 (45.8) 35.2 1861 (39.9) 27.0 4547 (45.6) 37.3 1124 (47.9) 35.5 2120 (57.9) 49.4 1537 (45.1) 27.5
Bad 2225 (19.7) 10.4 646 (13.9) 7.4 1518 (15.2) 10.5 269 (11.5) 7.0 960 (26.2) 10.9 521 (15.3) 8.5
Very bad 257 (2.3) 1.0 102 (2.2) 1.8 141 (1.4) 0.8 15 (0.6) 0.2 77 (2.1) 0.5 59 (1.7) 1.5
Arthritis 4381 (38.9) 23.3 2042 (43.8) 25.8 3,795 (38.1) 26.5 788 (33.6) 24.0 886 (24.2) 32.0 1346 (39.5) 20.6
Stroke 616 (5.5) 1.6 194 (4.2) 2.1 403 (4.0) 3.0 237 (10.1) 7.9 349 (9.6) 5.0 228 (6.7) 2.8
Angina 1791 (15.9) 7.8 931 (20) 12.9 2979 (29.9) 24.2 335 (14.3) 10.4 1743 (47.8) 24.8 526 (15.4) 7.9
Diabetes 799 (7.1) 2.9 175 (3.8) 2.1 533 (5.4) 3.2 454 (19.4) 9.8 344 (9.4) 3.5 354 (10.4) 3.2
COPD 1669 (14.8) 6.8 211 (4.5) 3.0 1736 (17.4) 12.9 488 (20.8) 17.5 1169 (32.0) 20.4 307 (9.0) 5.4
Asthma 1771 (15.8) 8.3 333 (7.2) 4.7 1871 (18.8) 14.3 425 (18.1) 13.0 1019 (27.9) 14.8 370 (10.9) 5.4
Depression 1920 (17.1) 13.5 823 (17.7) 13.2 3423 (34.3) 28.7 856 (36.5) 32.9 1646 (45.1) 30.1 440 (12.9) 9.8
Hypertension 5069 (45.3) 29.7 2429 (52.1) 41.0 3006 (30.2) 23.7 1025 (43.7) 22.5 2470 (67.6) 40.9 2442 (71.7) 48.9
Cataracts 3830 (34.2) 14.2 1144 (24.6) 13.9 4829 (48.6) 36.2 1057 (45.2) 29.8 1446 (40.2) 21.0 288 (8.5) 3.4
TMmost frequent
source of care
24 (0.2) 0.3 123 (2.6) 2.1 984 (9.9) 11.7 6 (0.3) 0.2 6 (0.2) 0.03 40 (1.2) 1.7
11 health
consultation in
previous 12m
6716 (59.5) 45.9 2971 (63.7) 52.0 8458 (84.8) 68.7 1001 (42.7) 31.5 2594 (70.8) 58.3 2072 (60.7) 38.1
11 TM consultation
in previous 12m
666 (5.9) 9.4 123 (2.6) 1.5 1852 (18.6) 19.0 3 (0.1) 0.1 6 (0.2) 0.04 3 (0.1) 0.02
Total reported
consultations
13 843 5868 17 939 2349 5243 4912
TM Consultations
[n, (% of total
reported consultations)]
1175 (8.5) 181 (3.1) 3589 (20.0) 4 (0.2) 6 (0.1) 3 (0.1)
Consultation cost
to household [u, (SD)]
214.63 (1199.99) 156 959.9 (774 203.9) 441.49 (1722.07) 671.56 (4188.36) 9303.35 (233 483.9) 119.91 (216.89)
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of people reported that their most frequent source of care was TM
and 19.0% of people reported at least one consultation with a TM
practitioner in the previous 12 months. In contrast, <3% reported
using TM as their most frequent source of care in China, Ghana,
Mexico, Russia and South Africa, and <2% reported using TM in
the last 12 months in Ghana, Mexico, Russia and South Africa.
Those who do make use of TM are more likely to be socio-econom-
ically disadvantaged.
Table 2. Characteristics of users of traditional medicine by study characteristics
China Ghana India
Modern
medicine
Traditional
medicine
P Modern
medicine
Traditional
medicine
P Modern
medicine
Traditional
medicine
P
Age group 0.009 0.041 0.684
<40 253 (4.2) 27 (4.0) v2 <0.001 226 (8.0) 4 (3.3) v2 0.365 1890 (28.6) 512 (27.7) v2 0.222
40–49 314 (5.2) 77 (11.5) 196 (6.9) 6 (4.9) 819 (12.4) 259 (14.0)
50–59 2282 (37.7) 232 (34.7) 864 (30.4) 39 (31.7) 1681 (25.5) 491 (26.5)
60–69 1662 (27.5) 176 (26.3) 677 (23.8) 29 (23.6) 1354 (20.5) 351 (19.0)
70þ 1544 (25.5) 157 (23.5) 879 (30.9) 45 (36.6) 862 (13.1) 239 (12.9)
Sex 0.623 0.408 0.684
Male 2654 (43.8) 300 (44.8) 1366 (48.0) 64 (52.0) 2466 (37.3) 701 (37.9)
Female 3401 (56.2) 369 (55.2) 1478 (52.0) 59 (48.0) 4140 (62.7) 1151 (62.2)
Income quintile <0.001 <0.001 <0.001
1 (poorest) 986 (16.4) 117 (17.8) 430 (15.2) 24 (19.5) 932 (14.1) 508 (27.4)
2 1079 (17.9) 130 (19.7) 521 (18.4) 25 (20.3) 1122 (17) 502 (27.1)
3 1166 (19.3) 142 (21.6) 578 (20.4) 43 (35) 1306 (19.8) 348 (18.8)
4 1345 (22.3) 185 (28.1) 632 (22.3) 24 (19.5) 1528 (23.2) 250 (13.5)
5 (richest) 1456 (24.1) 85 (12.9) 677 (23.9) 7 (5.7) 1701 (25.8) 243 (13.1)
Education <0.001 0.009 <0.001
Primary or less 3500 (57.8) 485 (72.5) 2032 (71.8) 101 (82.8) 4579 (69.3) 1488 (80.4)
Secondary 1297 (21.4) 130 (19.4) 173 (6.1) 5 (4.1) 813 (12.3) 189 (10.2)
Tertiary or more 1258 (20.8) 54 (8.1) 627 (22.1) 16 (13.1) 1214 (18.4) 175 (9.5)
Geography <0.001 0.016 <0.001
Urban 3048 (50.3) 87 (13) 1265 (44.5) 41 (33.3) 2047 (31) 176 (9.5)
Rural 3007 (49.7) 582 (87) 1579 (55.5) 82 (66.7) 4559 (69) 1676 (90.5)
Self-reported health <0.001 0.015 0.115
Very good 212 (3.5) 11 (1.7) 198 (6.7) 9 (7.3) 273 (4.1) 89 (4.8)
Good 1720 (28.4) 129 (19.3) 946 (33.3) 25 (20.3) 2146 (32.5) 622 (33.6)
Moderate 2813 (46.5) 292 (43.7) 1180 (41.5) 58 (47.2) 3152 (47.7) 753 (40.7)
Bad 1156 (19.1) 208 (31.1) 441 (15.5) 26 (21.1) 949 (14.4) 353 (19.1)
Very bad 146 (2.4) 28 (4.2) 78 (2.7) 5 (4.1) 85 (1.3) 35 (1.9)
Arthritis <0.001 0.46 0.085
Yes 2506 (41.4) 336 (50.2) 1304 (45.9) 61 (49.6) 2636 (39.9) 698 (37.7)
No 3546 (58.6) 333 (49.8) 1538 (54.1) 62 (50.4) 3970 (60.1) 1154 (62.3)
Stroke 0.606 0.077 0.469
Yes 359 (5.9) 43 (6.4) 129 (4.5) 10 (8.1) 281 (4.3) 71 (3.8)
No 5690 (94.1) 625 (93.6) 2712 (95.5) 113 (91.9) 6325 (95.8) 1781 (96.2)
Angina 0.476 0.653 0.005
Yes 1010 (16.7) 104 (15.6) 600 (21.1) 28 (22.8) 2099 (31.8) 525 (28.4)
No 5032 (83.3) 564 (84.4) 2241 (78.9) 95 (77.2) 4507 (68.2) 1327 (71.7)
Diabetes <0.001 0.522 <0.001
Yes 509 (8.4) 24 (3.6) 141 (5.0) 4 (3.25) 427 (6.5) 63 (3.4)
No 5532 (91.6) 644 (96.4) 2700 (95.0) 119 (96.8) 6179 (93.5) 1789 (96.6)
COPD 0.166 0.817 0.232
Yes 963 (15.9) 120 (18.0) 115 (4.1) 4 (3.25) 1213 (18.4) 317 (17.1)
No 5087 (84.1) 547 (82.0) 2726 (96.0) 119 (96.8) 5393 (81.6) 1535 (82.9)
Asthma 0.258 0.725 0.104
Yes 932 (15.5) 92 (13.8) 210 (7.4) 10 (8.13) 1312 (19.9) 336 (18.1)
No 5095 (84.5) 577 (86.3) 2631 (92.6) 113 (91.9) 5294 (80.1) 1516 (81.9)
Depression 0.169 <0.001 <0.001
Yes 1114 (18.4) 108 (16.2) 458 (16.1) 38 (30.9) 2251 (34.1) 768 (41.5)
No 4933 (81.6) 560 (83.8) 2385 (83.9) 85 (69.1) 4355 (65.9) 1084 (58.5)
Hypertension 0.001 0.007 <0.001
Yes 2910 (48.4) 276 (41.6) 1570 (55.2) 83 (67.5) 2139 (32.4) 465 (25.1)
No 3101 (51.6) 388 (58.4) 1273 (44.8) 40 (32.5) 4467 (67.6) 1386 (74.9)
Cataracts <0.001 0.678 <0.001
Yes 2106 (35.1) 172 (25.9) 759 (26.7) 35 (28.5) 3235 (49.1) 995 (53.8)
No 3902 (65.0) 493 (74.1) 2083 (73.3) 88 (71.5) 3348 (50.9) 855 (46.2)
Total cost to household 0.144 0.843 <0.001
Mean (SD) 220.37
(1221.72)
147.37
(855.52)
157 792.8
(787 230.3)
143 173.9
(364 428.2)
518.79
(1943.90)
183.80
(371.92)
COPD, chronic obstructive pulmonary disease. Where the independent variable is ordinal, P values calculated using Pearson’s correlation co-efficient. Where
the independent variable is binary, using Fisher’s exact test. Where the independent variable is continuous, using t-test. Where the independent variable is nominal
categorical, v2. For the association between age group and use of TM both Pearson’s correlation co-efficient and v2 are presented.
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Although use of TM is particularly low in the two sub-Saharan
African countries examined, its use is more prevalent in China and
India where the percentage use represents a very large population in
absolute terms. Chinese TM is a point of pride for the Chinese
Government. There is widespread belief that it works and it is part
of the history, culture and politics of the country (Goss et al. 2014).
Similarly in India, the government and the community may give cer-
tain traditional forms of medicine considerable respect, in terms of
policies and funding. Further, in both China and India many phys-
icians have training in traditional medicine and use traditional rem-
edies as part of their treatment recommendations (Hesketh and Zhu
1997; van Gameren 2010; Kay 2013) Even so, the use of TM for
healthcare in China and India is still considerably lower than com-
monly cited.
We are not the first to make the observation that use of TM is
lower than the 80% commonly reported by the WHO and others,
since a number of single country studies corroborate our findings.
Analysis of nationally representative South African population-
based surveys from 2005 to 2007 found <0.1% of the population
had used TM in the past month (down from a high of 12.7% a dec-
ade earlier Peltzer 2009). A 2008 survey of households in South
Africa (n¼4762) found that only 1.2% of respondents reported
using traditional healers (Nxumalo et al. 2011). A household survey
in Ghana (n¼4713) found that 83% used modern medicine as their
first choice when they had need for health services, whereas only
12% chose traditional care, of which 5.5% pursued self-care
through traditional methods and 6.5% consulted a traditional healer
(Sato 2012a). In the Kenya Integrated Household and Budget Survey
just 7.6% of respondents consulted ‘non-modern’ health care pro-
viders of which 0.2% visited a traditional healer (Awiti 2014).
Angmo et al. (2012) reported that in Ladakh, India the number of
traditional healers has fallen and the majority of the remaining prac-
titioners are aged over 51. The study found that younger generations
preferred other professions and there are areas where no apprentice
healers were in training (although note that in our analysis no par-
ticular age-group had greater use of TM Angmo et al. 2012).
Similar to our findings in Ghana and India, others have found
that those of a lower socio-economic status, who were unemployed,
lived in rural areas and reported low health status were more likely
to report use of traditional healers (van Gameren 2010; Nxumalo
et al. 2011; Sato 2012a; Awiti 2014). Whether this is the most ap-
propriate or simply the most accessible care for these marginalized
groups needs further investigation.
Our results give some indication that traditional medicine is used
as adjuvant therapy to modern medicine in China and India where
more respondents stated that they had used traditional medicine in
the last 12 months than answered that it was their main source of
care.
In Ghana and India we found that depression was more preva-
lent among users of TM, and in China and Ghana self-reported
health was lower among users of TM. A 2003 study in Tanzania
found that the prevalence of mental disorders among patients of
traditional healer centres was approximately twice that of patients
attending primary health care clinics (Ngoma 2003). Interpretations
of this may include the idea that when modern medicine leaves
something to be desired, as with some mental illness, traditional
medicine provides additional support. However, a national survey
of 3651 South African adults between 2002 and 2004 found that of
those with DSM-IV diagnoses for common mood, anxiety, and sub-
stance use disorders, just 9% had consulted traditional healers, 11%
had consulted religious of spiritual advisors and 29% had consulted
a modern medicine practitioner (Sorsdahl et al. 2009). In addition, a
study of psychiatric patients in Gujarat, India were largely dissatis-
fied with their experience of TM, and those treated by both TM and
modern medicine asserted that they would recommend modern
medicine over TM (Schoonover et al. 2014).
The strengths of our study are that we examined data from six
populous middle-income countries, including two Asian and two
Sub-Saharan African countries. TM use was ascertained by whether
participants reported a visit to a traditional healer within the last 12
months. This time limit allows current behaviour to be examined,
rather than what participants may have done in earlier periods of
their life, as well as reducing recall bias.
A limitation of our article is that due to the small numbers of
people utilizing TM it was not possible to draw conclusions about
the characteristics associated with use of TM in Mexico, Russia or
South Africa. Further limitations include that it is based on reported,
not observed behaviour, and therefore subject to reporting bias, for
example: It may be that someone who had visited a doctor practis-
ing a government accredited system of traditional medicine such as
Ayurveda in India would not have considered that they had visited
Table 3. Adjusted odd ratios and 95% confidence interval (CI) of
users of traditional healers by the study characteristics
China
OR (CI) P- value
Rurala 6.9 (5.4–8.9) <0.001
Income quintile 1.2 (1.1–1.2) <0.001
Self-reported health 1.5 (1.4–1.7) <0.001
Arthritis 1.4 (1.2–1.7) <0.001
Diabetes 0.6 (0.4–0.9) 0.028
Hypertension 0.8 (0.7–1) 0.039
Cataracts 0.6 (0.5–0.8) <0.001
<40b 0.8 (0.5–1.3) 0.395
40–49b 1.7 (1.2–2.4) 0.002
50–59b 0.7 (0.5–0.9) 0.002
60–69b 0.8 (0.6–1) 0.093
Ghana
OR (CI) P- value
Rurala 1.4 (1–2.2) 0.077
Income quintile 0.8 (0.7–0.9) 0.002
Self-reported health 1.1 (0.9–1.4) 0.27
Depression 2.2 (1.4–3.3) <0.001
Hypertension 1.7 (1.2–2.5) 0.007
<40b 0.5 (0.2–1.4) 0.204
40–49b 0.8 (0.3–1.9) 0.623
50–59b 1.1 (0.7–1.7) 0.767
60–69b 0.9 (0.6–1.5) 0.74
India
OR (CI) P- value
Rurala 1.3 (0.9–2) 0.217
Income quintile 0.8 (0.7–0.9) 0.001
Angina 1.0 (0.6–1.5) 0.838
Diabetes 0.8 (0.3–2.2) 0.644
Depression 2.4 (1.5–3.6) <0.001
Hypertension 1.8 (1.2–2.7) 0.005
Cataracts 0.9 (0.6–1.4) 0.665
Total costs 1.0 (1.0–1.0) 0.949
aGeography was entered as a categorical variable with urban as the refer-
ence category.
bAge group was entered as a categorical variable with age 70þ as the refer-
ence category.
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an traditional practitioner or there may be reluctance to report TM
use as Western education and lifestyles are seen as progressive i.e.
social desirability bias could influence reporting. However, it is un-
likely that this alone could account for the considerable distance of
these figures from the 80% commonly reported. In addition, the
questionnaire was not specifically designed to answer this question:
it is a general survey covering a range of health-related topics and
may not have probed this issue as carefully as a study designed to
answer this particular question. However, taken in combination
with observations made in single countries, it is hard to escape the
conclusion that TM use is on the decline and the drop in use seems
quite precipitate.
In conclusion, this study suggests that TM use in the countries
studied is considerably lower than commonly reported. While our
study documents the extent of TM use, it cannot provide an answer
as to what motivates its continued use: whether traditional healers
are used only when modern medicine is unavailable or unaffordable;
or whether they continue to be used because they provide effective
and acceptable treatments for some conditions. Other factors that
may contribute to the decline in use of TM include changes in social
trends and cultural beliefs and the political support and provision of
resources for training, practising and increasing public awareness of
modern medicine. Perhaps the policy position adopted by the WHO
and others should be more nuanced, not encouraging TM use for
health needs (e.g. malaria, angina) where use of TM is declining and
where there are reasons to doubt its effectiveness in comparison to
modern medicine. Instead further research should focus on under-
standing what role TM can play in improving population health and
wellbeing.
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